Aniridia

Aniridia is a condition where someone is born without a fully formed iris, the colored part of the eye. This is a rare condition. It can be present from birth or develop later.

Condition

What people with Aniridia report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Aniridia

What It Is

Aniridia is a rare condition in which the iris, the colored ring that controls how much light enters the eye, is partly or completely missing. It is usually present from birth and affects both eyes. Without a working iris the pupil cannot narrow in bright light, so glare and strong light sensitivity are common. The missing iris is the visible sign, but aniridia affects much more of the eye. Most people also have an underdeveloped fovea, the small central area of the retina responsible for sharp detail vision, which is the main reason vision is reduced from early childhood. Involuntary back-and-forth eye movements (nystagmus) are common. Over the years, problems with the cornea, the lens and the eye's drainage system can add to vision loss. Severity varies widely, even within one family: a few people have only subtle iris changes and good vision, while many adults have significant visual impairment.

Causes & Risk Factors

Most congenital aniridia is caused by a change in one copy of the PAX6 gene, which guides how the eye develops before birth. About two-thirds of people inherit it from a parent who also has aniridia, and the rest have a new genetic change with no family history. A parent with PAX6-related aniridia has a 50% chance of passing it to each child, because only one altered copy is needed to cause the condition. In some children, aniridia is part of a larger genetic deletion on chromosome 11 that also removes a nearby gene called WT1. This causes WAGR syndrome, named for its main features, which combines aniridia with a high risk of Wilms tumor (a childhood kidney cancer), genital and urinary differences, and developmental delay. Less often, aniridia occurs with other syndromes, such as Gillespie syndrome, which affects balance and coordination. Because PAX6 also acts in the brain and pancreas, some people with PAX6 changes have a reduced sense of smell or trouble regulating blood sugar. Aniridia can also result from a serious eye injury or eye surgery. That form is not inherited and can happen at any age.

How It's Diagnosed

Aniridia is often noticed in the first months of life, when parents see unusually dark or large-looking pupils, wandering or shaking eyes, or a baby who squints or turns away from light. An eye specialist confirms it with a detailed examination of the iris, cornea, lens, drainage angle, retina and optic nerve. Young children often need this first full examination under general anesthesia. Imaging of the back of the eye can show how well the fovea has formed, which helps predict vision. Genetic testing is recommended for anyone suspected of having congenital aniridia. It confirms the cause, informs family planning and, most importantly in a child, shows whether WT1 is also deleted. A child with that deletion has about a 50% chance of developing Wilms tumor, usually in early childhood, and is checked with a kidney ultrasound about every three months until age 7. Kidney ultrasounds are often started while genetic results are pending. Children with developmental delay may also need a neurological assessment, sometimes with magnetic resonance imaging (MRI) of the brain. A clinician also rules out look-alike conditions, such as a coloboma (a gap in the iris from incomplete closure during development), albinism and other developmental eye disorders.

Treatment Options

There is no cure for aniridia, and the underdeveloped fovea cannot be repaired. Treatment aims to make the most of the vision a person has, reduce light sensitivity and protect the eye from complications that would otherwise steadily take away more sight. The foundation is accurate glasses, prescribed early in childhood to prevent amblyopia (lazy eye), usually with tinted or photochromic lenses that darken outdoors to cut glare. Low vision rehabilitation adds magnifiers, telescopes for distance, video magnifiers and large-print or screen tools, along with orientation and mobility training for getting around safely. Contact lenses printed with an artificial iris are recommended by Japanese guidance, while European guidance advises against contact lenses for light sensitivity because the corneal surface in aniridia is fragile; this is a choice to make with a specialist. The corneal surface tends to break down over time, causing dryness, irritation and eventually clouding. Lubricating drops, anti-inflammatory drops such as cyclosporine, eye drops made from blood serum and specially fitted scleral lenses help protect it. For advanced clouding, stem cell or corneal transplants and artificial corneas are options, but vision gains are usually modest, rejection is common and long-term immune-suppressing medicine is often needed. Glaucoma is treated first with pressure-lowering eye drops, preferably preservative-free to spare the cornea, and then with surgery, where a drainage implant appears to work best. Cataracts are common, but surgery is usually delayed until the cataract is severe, because operating on an eye with aniridia carries higher risks of triggering glaucoma or worsening corneal disease. An artificial iris implant can reduce glare for some people but shares those risks. Research into eye-drop treatments that target the underlying genetic change is ongoing in clinical trials.

What to Expect

Aniridia is lifelong, and vision usually changes over time. In childhood, reduced sharpness mostly reflects the underdeveloped fovea and tends to be fairly stable. Later, cataract, glaucoma and corneal clouding can reduce vision further, and many adults meet the threshold for legal blindness, although some keep useful vision for decades. Glaucoma affects more than half of people with aniridia. It usually develops in late childhood or the teenage years and causes no symptoms early on, yet the damage it does to the optic nerve cannot be reversed. That is why eye pressure is checked at every visit throughout life, generally every six months in children under 8 and at least once a year after that. Thick corneas can make pressure readings misleading, so specialists adjust for corneal thickness. Day to day, light sensitivity and reduced vision shape school, work, driving eligibility, sports and travel. Children often need support at school, such as large print, seating near the board and assistive technology. Care works best from a team that may include a specialist eye center, an optometrist or orthoptist, low vision services, a genetic counselor and, for children with WAGR, a pediatric oncologist. Patient organizations can connect families with others who have the condition.

When to Seek Help

If a baby's pupils look unusually large or dark, the eyes shake or wander, or the baby seems unusually bothered by light, ask for an eye examination soon. Anyone diagnosed with aniridia who has not had genetic testing, or a child with WAGR who is not having regular kidney ultrasounds, should raise this with their care team. Contact the eye team right away for a sudden change in vision, everything suddenly looking dim, or new eye pain or swelling. In a child known to have WAGR, blood in the urine or high blood pressure needs prompt evaluation by the child's care team.

Questions to Ask Your Doctor

  1. 1.Has genetic testing shown whether this is PAX6-related aniridia or part of a syndrome such as WAGR, and what does that mean for other health checks?
  2. 2.Which parts of the eye are causing most of the vision loss, and which of them can be treated?
  3. 3.How often should eye pressure be checked, and how will we know if glaucoma is starting?
  4. 4.What low vision services, tinted lenses or school and workplace supports would help most right now?
  5. 5.If surgery is suggested, what improvement is realistic, and how does it affect the risk of glaucoma or corneal problems?

Last reviewed • Oct 2026

Educational content, not medical advice.